Skip to main content

Cryopreservation of umbilical cord blood with a novel freezing solution that mimics intracellular ionic composition.

Nicoud IB, Clarke DM, Taber G, Stolowski KM, Roberge SE, Song MK, Mathew AJ, Reems JA

Publication: Transfusion (2012) • Vol 52 • Page 2055-62PMID: 22320836View on PubMed

Purpose

The purpose of this paper was to determine the effects of type of cryoprotection solution and rate of addition on post-thaw recovery of cord blood cells.

Conclusion

Neither the type of cyroprotective solution nor the speed at which it was added affected post-thaw cell viability; however the number of viable cells post-thaw was significantly less than in fresh specimens. While the number of colony-forming units (CFUs) in CryoStar specimens were higher when cryoprotectant was added slowly rather than quickly, post-thaw viable total nucleated cells (TNCs), CFUs, and burst-forming unit-erythroids (BFUs) were not affected by type of cyroprotective solution. CD34+ cell counts were higher when specimens were frozen in CryoStar rather than an in-house solution and when frozen slowly rather than quickly, but only the difference due to freezing rate in the in-house solution was significant.

Studies (1)

Purpose

The purpose of this study was to determine the effects of type of cryoprotection solution and rate of addition on post-thaw recovery of cord blood cells. Cord blood was leukoenriched by the addition of hydroxyethyl starch and gravity sedimentation. Cells were cryopreserved in 12.5 mL in-house solution (20% DMSO, 20% dextran, 48% Hetastarch, 12% Acid-citrate-dextrose) or CryoStar. Both cryopreservation solutions were cooled to 2-8 degrees C and added either at 1 mL/min or by bolus infusion (approximately 25 mL/min) to cells on ice. After addition of the cryopreservation solution, specimens were transferred to freezer bags, frozen in a control rate freezer and transferred to vapor-phase liquid nitrogen for storage. Specimens were rapidly thawed at 37 degrees C and then placed in precooled conical tubes.

Summary of Findings

Neither the type of cyroprotective solution nor the speed at which it was added affected post-thaw cell viability; however the number of viable cells post-thaw was significantly less than in fresh specimens (92% versus 45-60%, p<0.05). While viable TNCs and CFUs were generally higher when specimens were frozen slowly rather than quickly, post-thaw viable TNC, CFUs, and BFUs were not affected by the type of cyroprotective solution, and the differences due to the speed of cryoprotective solution addition was only significant for CFUs in cells in CryoStar (p=0.044). CD34+ cell counts were higher when specimens were frozen in CryoStar rather than an in-house solution and when added slowly rather than rapidly, but only the difference due to blous versus slow-addition of the in-house solution was significant (p=0.002). The specimen temperature after the addition of the cryoprotective solution was 3.1-4.4 degrees C higher than pre-addition, but the temperature profile was dependent on solution and speed of addition, with the bolus addition resulting in higher temperatures during addition than after addition.

  • Biospecimens

    CellCord Blood
    FluidCord Blood
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Pregnant
  • Platforms

    Cell count/volumeLight microscopy
    Cell count/volumeMicrobiological assay
    Cell count/volumeFlow cytometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationCooling or freezing method/ rate
    Cryoprotectant added rapidly
    Cryoprotectant added slowly
    Biospecimen PreservationType of fixation/preservation
    None (fresh)
    Snap frozen
    StorageShort-term storage solution
    CryoStar
    In-house solution